Cell line · CVCL_1556
NCI-H322
Cancer cell line, Homo sapiens. Minimally invasive lung adenocarcinoma. 33 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. NCI-H322. Cell lines, record CVCL_1556. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1556
On this page
Cell line
As Cellosaurus gives it.
- Name
- NCI-H322
- Accession
- CVCL_1556
- RRID
- RRID:CVCL_1556
- Synonyms
- H322, H-322, H322T, NCI-H322T, NCIH322T, NCI-322, NCIH322
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 52Y
- Category
- Cancer cell line
- Diseases
- Minimally invasive lung adenocarcinoma (NCIt C2923)
- Derived from
- Lung (in situ)
- Cell type
- Club cell
- Entry created
- 2012-04-04
- Entry updated
- 2026-03-31
Source Cellosaurus
Problems1
| Problem | Cellosaurus's note |
|---|---|
| Caution | We are not certain that NCI-H322 and NCI-H322M are identical. |
Source Cellosaurus
Papers33
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Bivalent CD47 Immunotoxin for Targeted Therapy of Lung Cancer. | Biomedicines | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| DS-3939a: A TA-MUC1-Directed Antibody-Drug Conjugate with Broad Antitumor Activity. | Mol Cancer Ther | 2026 | Its Methods give the RRID and name the line | PubMed | |
| NECTIN4 regulates the cell surface expression of CD155 in non-small cell lung cancer cells and induces tumor resistance to PD-1 inhibitors. | Cancer Immunol Immunother | 2025 | Its Methods give the RRID and name the line | PubMed | |
| TERC promotes non-small cell lung cancer progression by facilitating the nuclear localization of TERT. | iScience | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Distinct Nrf2 Signaling Thresholds Mediate Lung Tumor Initiation and Progression. | Cancer Res | 2023 | Its Methods give the RRID and name the line | PubMed | |
| A tri-specific killer engager against mesothelin targets NK cells towards lung cancer. | Front Immunol | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Smoking-associated Downregulation of FILIP1L Enhances Lung Adenocarcinoma Progression Through Mucin Production, Inflammation, and Fibrosis. | Cancer Res Commun | 2022 | Its Methods give the RRID and name the line | PubMed | |
| From clinical specimens to human cancer preclinical models-a journey the NCI-cell line database-25 years later. | J Cell Biochem | 2020 | Cellosaurus cites it | PubMed | |
| Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer. | Elife | 2019 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 33
See all 33 papersRelatives2
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | NCI-H1334 | CVCL_3971 | Has a recorded problem | Cell lines |
| Derived from it | NCI-H322M | CVCL_1557 | Cell lines |
Cell banks4
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRL-5806 | Discontinued | Cellosaurus |
| CLS | 305839 | CLS | |
| ECACC | 95111734 | ECACC | |
| KCLB | 90322 | Discontinued | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1556
GET https://conductscience.org/api/cell-lines/v1/CVCL_1556/papers?page=2